Horenblas S - Search Results

1

Intravesical recurrence after bladder sparing treatment of small cell carcinoma of the bladder: Characteristics, treatment, and outcome.

van de Kamp M, Meijer R, Pos F, Kerst M, van Werkhoven E, van Rhijn B, Horenblas S, Bex A. van de Kamp M, et al. Among authors: horenblas s. Urol Oncol. 2018 Jun;36(6):307.e1-307.e8. doi: 10.1016/j.urolonc.2018.02.015. Epub 2018 Mar 23. Urol Oncol. 2018. PMID: 29580697 Clinical Trial.

2

Squamous cell carcinoma of the penis. II. Treatment of the primary tumor.

Horenblas S, van Tinteren H, Delemarre JF, Boon TA, Moonen LM, Lustig V. Horenblas S, et al. J Urol. 1992 Jun;147(6):1533-8. doi: 10.1016/s0022-5347(17)37618-8. J Urol. 1992. PMID: 1593683

3

Bladder conservation in selected T1G3 and muscle-invasive T2-T3a bladder carcinoma using combination therapy of surgery and iridium-192 implantation.

Moonen LM, Horenblas S, van der Voet JC, Nuyten MJ, Bartelink H. Moonen LM, et al. Among authors: horenblas s. Br J Urol. 1994 Sep;74(3):322-7. doi: 10.1111/j.1464-410x.1994.tb16620.x. Br J Urol. 1994. PMID: 7953264

4

Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes.

Horenblas S, van Tinteren H, Delemarre JF, Moonen LM, Lustig V, van Waardenburg EW. Horenblas S, et al. J Urol. 1993 Mar;149(3):492-7. doi: 10.1016/s0022-5347(17)36126-8. J Urol. 1993. PMID: 8437253

5

[Good results of bladder-preserving treatment in poorly differentiated and invasive bladder carcinoma using interstitial Iridium-192 radiotherapy].

Moonen LM, Horenblas S, Pos F, Schaefer BS, Meinhardt W, Bartelink H. Moonen LM, et al. Among authors: horenblas s. Ned Tijdschr Geneeskd. 1996 Jul 6;140(27):1406-10. Ned Tijdschr Geneeskd. 1996. PMID: 8766684 Dutch.

6

Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control.

Moonen L, vd Voet H, de Nijs R, Horenblas S, Hart AA, Bartelink H. Moonen L, et al. Among authors: horenblas s. Int J Radiat Oncol Biol Phys. 1998 Oct 1;42(3):525-30. doi: 10.1016/s0360-3016(98)00263-6. Int J Radiat Oncol Biol Phys. 1998. PMID: 9806510

7

Muscle-invasive bladder cancer treated with external beam radiotherapy: pretreatment prognostic factors and the predictive value of cystoscopic re-evaluation during treatment.

Moonen L, vd Voet H, de Nijs R, Hart AA, Horenblas S, Bartelink H. Moonen L, et al. Among authors: horenblas s. Radiother Oncol. 1998 Nov;49(2):149-55. doi: 10.1016/s0167-8140(98)00089-9. Radiother Oncol. 1998. PMID: 10052880

8

Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder.

Moonen L, Ong F, Gallee M, Verheij M, Horenblas S, Hart AA, Bartelink H. Moonen L, et al. Among authors: horenblas s. Int J Radiat Oncol Biol Phys. 2001 Apr 1;49(5):1305-10. doi: 10.1016/s0360-3016(00)01503-0. Int J Radiat Oncol Biol Phys. 2001. PMID: 11286838

9

Controlling gene expression in the urothelium using transgenic mice with inducible bladder specific Cre-lox recombination.

Bex A, Vooijs M, Horenblas S, Berns A. Bex A, et al. Among authors: horenblas s. J Urol. 2002 Dec;168(6):2641-4. doi: 10.1016/S0022-5347(05)64235-8. J Urol. 2002. PMID: 12442001

10

The role of initial immunotherapy as selection for nephrectomy in patients with metastatic renal cell carcinoma and the primary tumor in situ.

Bex A, Horenblas S, Meinhardt W, Verra N, de Gast GC. Bex A, et al. Among authors: horenblas s. Eur Urol. 2002 Dec;42(6):570-4; discussion 575-6. doi: 10.1016/s0302-2838(02)00404-9. Eur Urol. 2002. PMID: 12477652

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

352 results

Search Page

Filters